Aibotics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	0	-	-	-	-
Gross Profit	-	0	-	-	-	-
Selling, General & Admin	1.67	1.85	1.63	0.62	1.74	4.99
Operating Expenses	1.67	1.85	1.63	0.62	1.74	4.99
Operating Income	-1.67	-1.84	-1.63	-0.62	-1.74	-4.99
Interest Expense	-0.22	-0.23	-0.21	-0.56	-0.87	-0.15
Other Non Operating Income (Expenses)	-	-	-	-	-0.01	-
EBT Excluding Unusual Items	-1.9	-2.07	-1.85	-1.18	-2.61	-5.14
Other Unusual Items	-0.14	-0.14	-	-	-	-
Pretax Income	-2.04	-2.22	-1.85	-1.18	-2.61	-5.14
Earnings From Continuing Operations	-2.04	-2.22	-1.85	-1.18	-2.61	-5.14
Net Income	-2.04	-2.22	-1.85	-1.18	-2.61	-5.14
Net Income to Common	-2.04	-2.22	-1.85	-1.18	-2.61	-5.14
Shares Outstanding (Basic)	305	186	13	15	14	13
Shares Outstanding (Diluted)	305	186	13	15	14	13
Shares Change (YoY)	1373.91%	1291.99%	-10.09%	3.04%	7.70%	7.95%
EPS (Basic)	-0.01	-0.01	-0.14	-0.08	-0.18	-0.38
EPS (Diluted)	-0.01	-0.01	-0.14	-0.08	-0.18	-0.38
Free Cash Flow	-0.47	-0.46	-0.26	-0.11	-0.66	-0.24
Free Cash Flow Per Share	-0.00	-0.00	-0.02	-0.01	-0.04	-0.02
Gross Margin	-	100.00%	-	-	-	-
Operating Margin	-	-84501.74%	-	-	-	-
Profit Margin	-	-101500.27%	-	-	-	-
Free Cash Flow Margin	-	-20991.30%	-	-	-	-
EBITDA	-1	-1.18	-0.97	-0.56	-1.74	-4.99
D&A For EBITDA	0.67	0.67	0.67	0.06	0	0
EBIT	-1.67	-1.84	-1.63	-0.62	-1.74	-4.99